TREATMENT: The patient underwent uneventful vitreous biopsy (0.5 cc aspiration using a 23-gauge automated vitrectomy probe) and was given intravitreal vancomycin (1.0 mg in 0.1 ml) and ceftazidime (2.25 mg in 0.1 ml) injections. The patient was hospitalized and received intravenous cefazolin (1g, IV, q8h) as well as topical fortified vancomycin (50 mg/ml) alternating with ceftazidime (50 mg/ml) every half hour, atropine, 1% bid, and prednisolone acetate, 1%, q1h, OS.

ORGANISMS: Gram stain showed gram-positive cocci, and Staphylococcus epidermidis , sensitive to the therapeutic regimen, grew in culture on the first postoperative day.

INPATIENT FOLLOW-UP: The patient slowly improved during his 5-day hospital course with resolution of the hypopyon, increased corneal clarity, decreased cell and flare to 1+, and minimal resolution of anterior vitreous debris. His visual acuity remained 20/100 OD and hand motions OS. He was discharged and asked to take fortified vancomycin 50 mg/ml (q3h), atropine bid, and prednisolone acetate, 1%, q3h, OS.